Accuray (ARAY) Non Operating Investment Income (2020 - 2021)
Accuray (ARAY) posted Non Operating Investment Income of -$340000.0 for Q3 2021, down 133.3% on a QoQ basis from $1.0 million in Q1 2021, and down 1114.29% year-over-year from $33521.1 in Q3 2020.
Powered by 
Analysis
Accuray (ARAY) Non Operating Investment Income (2020 - 2021) Analysis & Trends
Accuray has reported Non Operating Investment Income for 2 years, with the latest figure at -$340000.0 in Q3 2021.
- On a quarterly basis, Non Operating Investment Income fell 1114.29% year-over-year to -$340000.0 in Q3 2021; TTM through Sep 2021 was $1.8 million, a N/A change from a year earlier, with the FY2021 full-year figure at $872000.0, up 685.23% from the prior year.
- Non Operating Investment Income was -$340000.0 for Q3 2021 at Accuray, down from $1.0 million in the prior quarter.
- The five-year high for Non Operating Investment Income was $1.1 million in Q4 2020, with the low at -$371000.0 in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | - |
| 10 | Accuray | 31.25 Mn | -11.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -340,000.00 |
| Mar 31, 2021 | 1.02 Mn |
| Dec 31, 2020 | 1.12 Mn |
| Sep 30, 2020 | -28,000.00 |
| Jun 30, 2020 | -371,000.00 |
| Mar 31, 2020 | 222,000.00 |